Human Mesenchymal Stem Cell-Derived Miniature Joint System for Disease Modeling and Drug Testing

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Organ-on-a-Chip Technology

Background:

• Osteoarthritis (OA) is a debilitating knee joint disease affecting all joint components.
• Studying intra-articular tissue crosstalk is crucial for understanding OA pathogenesis and developing treatments.
• Existing in vitro models lack the complexity to replicate native joint interactions.

Purpose of the Study:

• To develop a human cell-derived microphysiological system simulating intra-articular tissue crosstalk.
• To create a miniature joint (miniJoint) model for studying knee joint diseases and testing therapeutics.
• To validate the miniJoint's ability to predict in vivo drug efficacy.

Main Methods:

• Generation of a microfluidics-enabled bioreactor integrating engineered osteochondral, synovial-like, and adipose tissues.
• Culturing human mesenchymal stem cells to form the miniJoint system.
• Exposure of the miniJoint to interleukin-1β to induce inflammation and testing drug responses.

Main Results:

• The miniJoint successfully maintained distinct tissue phenotypes while enabling crosstalk.
• Inflammatory responses in the miniJoint mimicked those observed in human joint diseases.
• The model accurately predicted the therapeutic effects of naproxen and other potential OA drugs.

Conclusions:

• The miniJoint serves as a robust organ chip model for studying joint pathology.
• This system facilitates the investigation of complex tissue interactions in knee joint diseases.
• The miniJoint holds significant potential for accelerating the development of novel therapeutic interventions for osteoarthritis.